Pharmafile Logo
Pharmafocus logo
Advanced Search

David Gallagher to head up IPHA

October 4, 2010
Sales and Marketing IPHA, appointment, sales and marketing

Pfizer Healthcare Ireland’s managing director David Gallagher has been elected president of the Irish Pharmaceutical Healthcare Association (IPHA). David has …

Appointment

Talking R&D: US regulatory guidelines

October 4, 2010
Manufacturing and Production, Research and Development Talking R&D, eCTD submissions

Recent speculation surrounding current diabetes drugs and their long term effect on cardiovascular health has heads spinning in the pharmaceutical …

Feature

Zydus Nycomed’s API plant to start production soon

October 4, 2010
Manufacturing and Production API, India, Nycomed, Zydus Cadila

Nycomed has said that construction and validation of an active pharmaceutical ingredient manufacturing unit at its plant in Navi Mumbai, …

News

AZ-BMS diabetes drug impresses in phase III trials

October 1, 2010
Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes

AstraZeneca and Bristol Myers Squibb’s potential first-in-class diabetes drug dapagliflozin has shown strong results in a late stage trial. It …

News

FDA unveils new trial data rules

October 1, 2010
Research and Development FDA, clinical trials, pharmacovigilance

The FDA has clarified its rules on what safety information must be reported during clinical trials of investigational drugs and …

News

BMS poaches AZ’s head of global medical affairs

October 1, 2010
Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Dr Rick Lones as executive medical director in the UK. He joins BMS from AstraZeneca, where …

Appointment

New digital agency Intensity launched

October 1, 2010
Medical Communications Creston, Intensity, OnMedica, Pan, Red Door

Medical communications group Creston has launched a new digital specialist agency called Intensity Digital. The start-up agency aims to serve …

News

J&J chief admits mistakes at Congressional hearing

October 1, 2010
Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …

News

Sanofi signs $2.2bn CRO deal

October 1, 2010
Research and Development CRO, Covance, Sanofi-Aventis

Sanofi-Aventis has signed a major deal to contract out a wide range of drug development and laboratory services as part …

News

The Food and Drug Administration (FDA)

October 1, 2010
FDA, Food and Drug Administration

The current incarnation of the Food and Drug Administration (FDA) was established in 1930, but the US regulator’s modern functions …

News

National Institute for health and Clinical Excellence (NICE)

October 1, 2010
NICE, National Institute for health and Clinical Excellence

The National Institute for health and Clinical Excellence (NICE) is a UK cost-effectiveness body that assesses a drug’s cost against …

News

Doctors express serious doubts about health reforms

October 1, 2010
Sales and Marketing BMA, NHS, healthcare reform, reform

The government’s plans for radical reform of the NHS has come under attack from doctors’ association the BMA, which says …

News

GPs urge more patient ‘self care’ for minor ailments

September 30, 2010
Medical Communications Doctors.net.uk, OTC, doctors, pharma, simon grime

 Research by Doctors.net.uk, on behalf of OTC Bulletin, has revealed that nine out of ten general practitioners in the UK …

News
Press release

Caelyx rights to revert back to Janssen

September 30, 2010
Sales and Marketing Caelyx, Janssen, Merck

Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …

News
Herceptin packs

New Herceptin data sways NICE

September 30, 2010
Sales and Marketing Herceptin, NICE, Roche

NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …

News

Termeer exit could help Sanofi

September 30, 2010
Sales and Marketing Genzyme, M&A, MA, Sanofi

Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …

News

Nestlé to pioneer ‘health science nutrition’

September 29, 2010
Sales and Marketing Alzheimer's, health science nutrition, nestle

Nestlé is to take on conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s with the creation of two research …

News
EuropeanParliamentWEB

Europe votes for patients’ access to information

September 29, 2010
Medical Communications, Sales and Marketing Europe, medicines information

Members of the European Parliament have voted in favour of giving patients across Europe access to ‘high quality information’ on …

News

ClinTec recruits former Wyeth VP

September 29, 2010
Research and Development ClinTec, appointment, research and development

Glasgow, UK-based contract research organisation ClinTec has expanded its US operations with the appointment of new executive vice president Dr …

Appointment
FDA director of manufacturing and product quality Rich Friedman

The FDA Interview: Is pharma getting worse at manufacturing?

September 29, 2010
Manufacturing and Production, Research and Development FDA, manufacturing, manufacturing compliance

It seems that barely a week goes by at the moment without news of another pharmaceutical company falling foul of …

Feature
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026